LICENSE PATHOGEN REDUCTION TECHNOLOGY (PRT) FOR RED BLOOD CELL (RBC) COMPONENTS TO REDUCE THE RISK OF TRANSFUSION-TRANSMITTED INFECTION (TTI) BY RECOGNIZED, EMERGING, EPIDEMIC, AND ENDEMIC PATHOGENS THAT IS CAPABLE OF TREATING OVER 10 MILLION RBC COM

Department of Health and Human Services